Research Grants and awards 4 year PhD positions

Criteria for application

In 2020 funding will be made available for 6 RIHS Junior Researcher projects. The call for these PhD grants is closed. Find the criteria here. read more

Criteria for application

Criteria for application 

  • The first applicant is a RIHS affiliated (junior)PI or a researcher within a RIHS affiliated (junior)PI group (PI predicate per January 1, 2019).
  • The work of the PhD has to be done primarily within that (j)PI group.
  • Only one project per (j)PI group can be submitted.
  • The project should be not previously awarded nor currently under review by another grant agency.
  • The theme leader should confirm that the project fits and strengthens the focus of the theme.
  • Applicants (i.e. PI group) who received a project in the Junior researcher round 2019 are not eligible for this round.
  • The project should result in a PhD graduation within Radboudumc.

Priority criteria

Conditional on sufficient quality, relevance, feasibility and fit within a research theme, project proposals will be prioritized in the following order:
  1. A proposal that was evaluated externally since January 1, 2018 and received excellent reviews but was not granted (such as a VENI proposal). Attach documents such as the original proposal, reviews, rebuttal and decision letter.
  2. A proposal that develops and/or optimizes new methodology for the health sciences (such as a new measurement technique, a new research design or a new analysis tool).
  3. A proposal that creates a new collaboration outside Radboudumc, within Radboud University (including other faculties) or with an international partner (the PhD should spend at least 6 months at the partner’s institute).
  4. Other.
The project proposals (also the externally evaluated proposals) should be submitted as a pre-proposal using the application form.

Application procedure

The RIHS Grant Review Committee will assess the pre-proposals on the aspects. A maximum of 10-15 projects will be selected by the Grant Review Committee for submission of a full proposal. read more

Application procedure

The procedure:

  • The RIHS Grant Review Committee will assess the pre-proposals on the aspects: 1. suitability of the project for a junior researcher; 2. innovative content; 3. scientific or societal relevance.
  • A maximum of 10-15 projects will be selected by the Grant Review Committee for submission of a full proposal.
  • The full proposals will be assessed by the RIHS Grant Review Committee for 1. suitability of the project for a junior researcher; 2. innovative content; 3. scientific quality; 4. preliminary results; 5. scientific or societal relevance; 6. collaboration.
  • An opportunity for a concise rebuttal to the review will be provided.
  • The Grant Review Committee will come to an advice based on the review and the rebuttal.
  • The Committee’s advice will be handed to the scientific director for prioritization and final decision.

Time line

Submission of pre-proposals (*) 17 May 2019
Decision pre-proposals to applicant 13 June 2019
Submission of full proposals (*) 12 July 2019, 11h
Pre-advice to applicant  2 September 2019
Rebuttal by applicant (*) 13 September 2019, 11h
Final decision to applicant End of September 2019
(*) all submissions to rihs@radboudumc.nl

Information

research policy advisor RIHS and RIMLS

+31 (0)24 309 26 10
contact form

Previous winners



2020

Applicants Title Theme(s)                
Geert Litjens Improving efficiency and accuracy of skin cancer diagnostics through implementation of ‘deep learning’-based tissue analysis.
 
Healthcare Improvement Science
Nico Verdonschot Orthos Paedos: Optimized Pre-Operative Planning for Correction of the Scoliotic Spine.
 
Reconstructive and Regenerative Medicine
Camiel Rosman QuantiTative MRI of Esophageal Cancer ­ QuantiTEC.
 
Tumors of the digestrive tract  
Saskia de Wildt POINTeR: Pediatric Organoids to elucidate INtestinal Drug TranspoRt.
 
Renal disorders
Jakko van Ingen Designing new, improved treatment regimens for nontuberculous mycobacterial diseases using the hollow fiber model.
 
Infectious disease & Global Health
Tessel Galesloot New statistical methods enabling recurrent event genome-wide analyses with an application to bladder cancer.
 
Urological cancers


2019

Applicants

Title

Theme(s)                

Debby Gerritsen

DIAS: Enriching personalized depression care by learning from successfully used Deliberate  and Intuitive Antidepressant Strategies in nursing
homes.

Healthcare Improvement Science

Reinout van Crevel

Trained innate immunity and resistance to Mycobader¡um tuberculosis infection

Infectious disease & Global Health

Dick Thijssen

Stand up agaInsT dementia (SIT-ALARM): Understanding cerebrovascular physiologicAL changes underlying the impact of sedentARy behaviour on cognitive impairMent.

Vascular damage

Jan Bussink

Automated assessment of radiotherapy induced cardiac toxicity.

Rare cancers

Chris de Korte

Ultrafast ultrasonic COMpound Push wave imAging and Strain eStimation (Ultra-COMPASS) for personalized stroke risk stratification.

Vascular damage

Cecile Magis-Escurra & Bram van Ginneken

Tuberculosis mass screening with digital X-ray (CAD4TB) and a portable, ‘point-of-care’ electronic nose device in a high-risk population in Paraguay.

Infectious disease & Global Health  , Rare Cancers



2018

Applicants

Title

Theme(s)                

Tom Scheenen

A personalized image- based assessment of metastatic potential of prostate cancer

Urological cancers

 

 

 

Jeroen van der Laak & Nico Karssemeijer

Deep learning based histological assessment of the stroma for improved risk stratification ductal carcinoma   in situ (DCIS) patients.

Women's cancers

 

 

 

Loes van der Zanden & Nel Roeleveld

SOlitary Functioning kIdney: Aetiology and Prognosis (SOFIA Project).

Reconstructive and regenerative medicine

 

 

 

Jan Rongen & Maroeska Rovers

Tailoring arthroscopic knee surgery to those patients with degenerative meniscus rears that benefit most: a meta analysis using individual participant data from all clinical trials.

Urological cancers

 

 

 

Tim Dijkema & Hans Kaanders

Towards MRI- guided treatment of head-and-neck cancer.

Rare cancers

 

 

 

Sebastiaan van de Groes & Nico Verdonschot

3D-patient specific surgical planning and intra-operative execution based on 4D imaging: clinical implementation in complec knee re-alignement surgery.

Regenerative and reconstructive medicine



2017

Applicants

Title

Theme(s)                

Dr René Melis

The effects of sedentary behavior on cognitive function and cognitive decline

Healthcare improvement science

 

 

 

Dr Marieke Coenen

Genetics of Osteosarcoma (GO): Towards personalized treatment of osteosarcoma

Inflammatory diseses   

 

 

 

Prof. Bart-Jan Kullberg

Fungal infections as major side effect of IL-17-targeted therapy: identifying its incidence, severity, immunogenetics, and management of patients at risk

Infectious diseases & 
Global Health

 

 

 

Dr Rob Aarnoutse

Development of a treatment regimen for resistant TB meningitis

Infectious diseases & 
Global Health

 

 

 

Dr Carla van Herpen

PET/CT imaging of PD-L1 expression in patients with advanced head and neck cancer

Rare cancers

 

 

 

Prof. Nicole Blijlevens 

The role of interleukin-1 inhibition in the management of inflammation during neutropenia in hematopoietic stem cell transplant recipients with multiple myeloma

Rare cancers



2016

Applicants

Title

Theme(s)                

Dr Mireille Broeders/
Dr Sandra Geurts 
Prof. Iris Nagtegaal

Tailoring breast and colorectal cancer 
follow-up to the length of the preclinical 
phase of cancer recurrence: a methodological 
framework built on experiences from primary screening

Women’s cancers & 
Tumours of the 
digestive tract

 

 

 

Prof. Nico Karssemeijer/
Dr Jeroen van der Laak

Deep neural networks to assess the tumor 
stroma for breast cancer prognostication

Women's cancers   

 

 

 

Prof. Bart Kiemeney/
Dr Sita Vermeulen 
Prof. Mihai Netea
Prof. Leo Joosten

DNA variation markers for BCG response in 
urinary bladder cancer: a roundtrip between 
mechanism and evidence

Urological cancers 
& Infectious diseases & 
Global Health

 

 

 

Dr Tom Scheenen 
Prof. Jelle Barentsz

Nanotechnology at ultra-high magnetic field:
towards in vivo detection of small lymph node 
metastases with MRI

Urological cancers

 

 

 

Prof. Jack Wetzels/
Dr Jan van den Brand

Predicting Progression in CKD

Renal disorders

 

 

 

Prof. Hans de Wilt 
Prof. Otto Boerman/
Dr Mark Rijpkema 

Fluorescence image-guided surgery in
patients with peroneal carcinomatosis of colorectal origin

Tumours of the 
digestive tract



2015

Applicants

Title

Dr Teun Bousema

Defining antigen specific signatures of pretective immunity to malaria (DESIMAL)

Dr Mireille Broeders

Acceptability of personalised risk-based breast cancer screening and prevention approaches among women in Europe

Prof. Maria Hopman

The cardiac consequences of endurance exercise: can too much exercise hurt the heart?

Prof. Nico Karssemeijer

Quantative pathological analysis for improved prognostication of triple negative breast cancer

Dr René Melis

Understanding and Predicting Personalised Growth curves to Aid Individualized care in late onset Dementia from diagnosis and onwards: the UPPGRAID study 

Dr Nel Roeleveld

Patterns of blood pressure change across pregnancy and adverse perinatal outcomes: development and application of big data technologies

Dr Dick Thijssen

Non-invasive surrogate for right vetricular pressure-volume loops: Development, validation, and prognostic value of an innovative and novel echocardiographic tool in pulmonary artery hypertension

Prof. Jack Wetzels

Unraveling the pathogenesis of idiopathic nephrotic syndrome: a search for plasma-permeability factors



2014

Applicants

Title

Dr Teun Bousema

The effect of G6PD variation on utilising single dose primaquine to block transmission of malaria

Dr Sita Vermeulen, Prof. Bart Kiemeney

Integration of evidence from different platforms and populations in de quest for rare genetic risk factors for urinary bladder cancer

Dr Vivian Weerdesteyn, Prof. Sander Geurts, Prof. Bas Bloem

Rethinking postural stability after stroke

Dr Ph. van de Wees, Prof Maroeska Rovers, Prof. Gert Westert, Prof. Ria Nijhuis- van der Sanden

Developing and applying Patient Reported Outcome Measures (PROMs) for clinical decision-making and performance measurement in surgery



2013

Applicants

Title

Dr. Lisette Schoonhoven, Prof.  Theo van Achterberg

Impact van verpleegkundige interventies op delier op de IC.

Dr. Tjard Schermer, Drs. Erik Bischoff

Een "slimme" exacerbatiemonitor ter ondersteuning van zelfmanagement van exacerbaties

Dr Mireille Broeders, Prof. Andre Verbeek

Borstkankerscreening op maat: de balans tussen voor- en nadelen binnen risicogroepen

Prof. Didi Braat

Fertiliteitspreservatie bij jonge vrouwen met kanker. Verbetering in de zorg.



2012

Applicants

Title

Prof. A. Evers, dr. H. van Middendorp

The role of pre-cortisol treatment for stress exposure and stress management: an innovative

Prof. Carel Hoyng, prof. Gert-Jan van der Wilt, dr. Maroeska Rovers

Toward a personalized medicine in patients with age-related macular degeneration



2011

Applicants

Title

Dr. L. van den Bemt, dr. Tjard Schermer

Impact on patient care of the Paediatric Electronic quality of Life Instrument for Childhood Asthma (Pelican) instrument in the Netherlands

Prof. Evert van Leeuwen, prof. P. de Smet

Ethical Warrants of Guidelines for Diagnosis and Treatment of Children and Adolescents



2010

Applicants

Title

Prof. A. Geurts, Dr Vivian
Weerdesteyn

Why humans fall: the next step to successful balance

Dr. Sita Vermeulen, Prof. D.W. Swinkels

Multivariate association analysis of genome-wide DNA variation: revealing the link between hepcidin, iron, and atherosclerosis

Dr. J. Deinum, Dr. J. Bakx

Primary aldosteronism in newly diagnosed hypertensive patients in general practice



2009

Applicants

Title

Dr Steven Teerenstra, Dr G. Borm

Betere methodes voor studies die het welbevinden van groepen ('clusters') van ouderen vergelijken, wanneer er weinig clusters zijn

Dr Marieke Coenen

Prediction of treatment outcome in rheumatoid arthritis: Biomarker identification with a focus on genes and proteins and their mode of action